Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NooCube is a caffeine-free, natural, daily cognitive supplement formulated to support memory, focus, mental processing speed, and stress reduction. Its proprietary blend includes 13 science-backed ingredients, such as Bacopa monnieri, Lutemax® 2020 (a marigold extract), L-tyrosine, and Panax ginseng. The product is marketed for healthy adults seeking cognitive enhancement without prescription medications. It is not a drug and does not treat, diagnose, or cure medical conditions, but about 90% of users report improved focus within 4 weeks of consistent use[3][1]. NooCube distinguishes itself through ingredient transparency and an all-in-one nootropic stack, eliminating the need to combine multiple supplements[1][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NooCube.